Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Douglas Forsyth

Director at Inhibrx Biosciences, Inc. (INBX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$49K
Total bought / sold$287K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Sep 8SEC INBXInhibrx Biosciences, Inc. Buy 2,500227,064 held (+1%) $114.65 $287K -17.1%
  • Buy

    Director Douglas Forsyth bought $287K of INBX at $114.65 — first open-market purchase in our records.